Literature DB >> 1183727

Enzymes of glucose metabolism and of the citrate cleavage pathway in adipose tissue of normal and diabetic subjects.

F Belfiore, A M Rabuazzo, E Napoli, V Borzi, L Lo Vecchio.   

Abstract

Enzyme activities operative in glucose degradation and citrate cleavage pathway were studied in the adipose tissue of twenty-four patients with adult-onset diabetes and normal body weight, aged 59+/-9 years, and twenty-four matched controls. In normal tissue, type II (heat-inactivated) hexokinase moderately predominated over type I (heat-resistant). 6-Phosphofructokinase had an extremely low activity, which was by far the lowest among the ten glycolytic enzyme activities investigated, and which therefore might greatly limit the glycolytic rate. The level of glucose-6-phosphate dehydrogenase and phosphogluconate dehydrogenase (decarboxylating) was elevated above that occurring in other tissues. This, especially if considered together with the low 6-phosphofructokinase activity, would suggest a major role of pentose cycle in glucose degradation. Of the citrate cleavage pathway enzymes, ATP citrate-lyase, although having a lower activity than malate dehydrogenase and malate dehydrogenase (decarboxylating) (NADP), was readily measurable, which contrasts with previous data by others. This finding is consistent with the occurrence of lipogenetic capacity in human adipose tissue. In diabetic tissue, there was a decreased activity, both on a protein and on a wet-weight basis, of enzymes concerned with the glucose entry into metabolic pathways, namely hexokinase (both type I and, especially, type II) and pentose cycle dehydrogenases, as well as of pyruvate kinase. This could be connected with the defective glucose utilization by adipose tissue in diabetes. Beside the above-mentioned dehydrogenases, malate dehydrogenase (decarboxylating) (NADP) was also diminished. The reduction of these NADPH-forming enzymes, which supply reducing equivalents for fatty acid synthesis, would suggest a depressed lipogenesis.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1183727     DOI: 10.2337/diab.24.10.865

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

1.  Studies on the mechanism of action of sulphonylureas in type II diabetic subjects: gliquidone.

Authors:  E Bonora; P Moghetti; M Querena; M Zenere; V Cacciatori; F Tosi; D Travia; G Zoppini; M Muggeo
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

Review 2.  Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease.

Authors:  Giuseppe Verdile; Kevin N Keane; Vinicius F Cruzat; Sandra Medic; Miheer Sabale; Joanne Rowles; Nadeeja Wijesekara; Ralph N Martins; Paul E Fraser; Philip Newsholme
Journal:  Mediators Inflamm       Date:  2015-11-26       Impact factor: 4.711

Review 3.  Diabetes and Alzheimer disease, two overlapping pathologies with the same background: oxidative stress.

Authors:  Sergio Rosales-Corral; Dun-Xian Tan; Lucien Manchester; Russel J Reiter
Journal:  Oxid Med Cell Longev       Date:  2015-02-26       Impact factor: 6.543

4.  Aminoguanidine partially prevents the reduction in liver pyruvate kinase activity in diabetic rats.

Authors:  Alimohammad Amiri Majd; Mohammad Taghi Goodarzi; Taghi Hassanzadeh; Heidar Tavilani; Jamshid Karimi
Journal:  Adv Biomed Res       Date:  2014-12-31

5.  Gender-specific effects of intrauterine growth restriction on the adipose tissue of adult rats: a proteomic approach.

Authors:  Adriana Pereira de Souza; Amanda Paula Pedroso; Regina Lúcia Harumi Watanabe; Ana Paula Segantine Dornellas; Valter Tadeu Boldarine; Helen Julie Laure; Claudia Maria Oller do Nascimento; Lila Missae Oyama; José Cesar Rosa; Eliane Beraldi Ribeiro
Journal:  Proteome Sci       Date:  2015-12-02       Impact factor: 2.480

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.